Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Collection of Effectiveness and Safety Data From Patients Treated With Liraglutide or DPP-4 Inhibitor in Primary Care in Europe

NCT01890993 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01890993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01890993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Collection of Effectiveness and Safety Data From Patients Treated With Liraglutide or DPP-4 Inhibitor in Primary Care in Europe
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
August 31, 2013
Completion date
June 30, 2014
Enrollment
952 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2